Research to Prevent Blindness

Research to Prevent Blindness Celebrates 60th Anniversary

Today, Research to Prevent Blindness (RPB) celebrates the 60th anniversary of its incorporation. With the help of some of our grantees, we pause to reflect on our many sight-saving accomplishments over the past 60 years:

In honor of RPB’s sight-saving work, please consider making an anniversary donation of $60 to allow us to keep supporting incredible scientific discoveries. All donations to RPB go directly to research and are matched by RPB.

Thank you for your support of RPB - we are grateful to everyone who has played a part in our success over the past 60 years!

top

February 4, 2020

Feature Story

For the Media

Top Story

Related News: Feature Story, For the Media, Top Story

In Memoriam: David F. Weeks

The RPB Chairman Emeritus made an incredible impact on the vision research field, from his efforts to initiate support for the creation of the National Eye Institute to his decades-long leadership of RPB.

Research to Prevent Blindness and American Academy of Ophthalmology Award Grants for Big Data Research to Improve Patient Care

Award recipients to use IRIS Registry database to improve diagnosis and treatment of eye disease

Research to Prevent Blindness and Association of University Professors of Ophthalmology Announce 2022 Recipient of RPB David F. Weeks Award for Outstanding Vision Research

Donald Zack, MD, PhD, is recognized for ground-breaking contributions to the field of vision research.

In Memoriam: William J. vanden Heuvel

The RPB Board Member, who was a U.S. Ambassador, lawyer, and champion of human rights, worked tirelessly for causes he believed in.

Watch The Video

RPB HOSTS VIRTUAL EVENT ON LOW VISION

The online event featured RPB grantees and is now available to view on demand.

Research to Prevent Blindness and The Glaucoma Foundation Offer Critical Funding for Early-Career Vision Scientists

The Career Advancement Awards—one focused specifically on glaucoma research—support novel science related to eye diseases by up-and-coming researchers.